Aims: European Systematic Coronary Risk Assessment 2 for Older Persons (SCORE2-OP) model has shown modest performance when externally validated in selected cohorts. We aim to investigate its predictive performance and clinical utility for 10-years cardiovascular (CV) risk in an unbiased and representative cohort of older people of a low CV risk country. Furthermore, we explore whether other clinical or echocardiographic features could improve its performance.
Methods and results: A cohort of randomly selected individuals ≥ 65 years from a primary care population of Barcelona without established cardiovascular disease included 791 patients (63.1% female, median age 76 years, median follow-up 11.8 years). The model's performance yielded a Harrell's C-statistic of 0.706 (95% CI 0.659-0.753) for the primary endpoint (myocardial infarction, stroke, cardiovascular mortality) and 0.692 (95% CI 0.649-0.734) for the secondary endpoint (primary endpoint plus heart failure hospitalization), with better discrimination in females. SCORE2-OP underestimated the risk of primary endpoint in women (Expected[E]/Observed[O]=0.77), slightly overestimated in men (E/O=1.06), and systematically underestimated the risk of the secondary endpoint (E/O=0.52). Decision curve analysis showed net clinical benefit across a 7.5-30% risk range for primary endpoint. Valvular calcification was the only variable that significantly improved 10-year SCORE2-OP risk performance for both primary and secondary endpoints, with a change in Harrell's C of 0.028 (P=0.017).
Conclusion: In a low CV risk country, SCORE2-OP showed notable discrimination and excellent calibration to predict 10-year cardiovascular risk, with better performance in females. Incorporating valvular calcification in a future revised score may enhance accuracy and reduce unnecessary treatments.
Keywords: SCORE2-OP; cardiovascular disease; elderly; external validation; primary prevention; risk prediction models.
The European Systematic COronary Risk Evaluation 2 for Old Persons (SCORE2-OP) was developed to predict 10-year cardiovascular risk in the elderly, aiming to guide therapies whose effectiveness depends on the baseline risk profile. This research, involving 791 elderly individuals randomly selected from a low-risk Mediterranean area assessed the accuracy of the SCORE2-OP model in this population. The primary insights from the study are: The SCORE2-OP model's discrimination was reasonably good, but performed better in female than in male patients. Despite good overall calibration, there is a tendency to underestimate the risk of cardiovascular events during follow-up, especially when heart failure admissions are considered. Exploring alternative clinical and echocardiographic features may improve the model's performance.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.